IBRX
USDImmunityBio Inc. Common Stock
$2.130+0.050 (2.404%)
Real-time Price
Healthcare
Biotechnology
United States
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$2.080
High
$2.140
Low
$2.000
Volume
0.82M
Company Fundamentals
Market Cap
2.1B
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
9.96M
Exchange
NMS
Currency
USD
52-Week Range
Low $1.83Current $2.130High $5.88
Related News
BusinessWire
Driven by Strong Demand, ImmunityBio Reports 467% Year-to-Date Unit Growth and $75 Million in Sales Year-to-Date, Up 434% from Q3 2024
Q3 2025 Revenue and Other Income Growth with Continued Strong Sales Momentum: $33.7 million of total revenue and other income, up from $26.4 million in Q2 2025. Product Revenue: Up 434% in Q3 2025 versus Q3 2024,
View more
Related Stocks
FAASW
DigiAsia Corp. Warrant
NASDAQ
Computer Softwa...
GMED
Globus Medical Inc.
NASDAQ
Medical/Dental ...
MSBIP
Midland States Bancorp Inc. Depositary Shares Each Representing a 1/40th Interest in a Share of 7.750% Fixed-Rate Reset Non-Cumulative Perpetual Preferred Stock Series A
NASDAQ
Major Banks
COYA
Coya Therapeutics Inc.
NASDAQ
Biotechnology: ...
JFR
Nuveen Floating Rate Income Fund
NASDAQ
Trusts Except E...
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.